Total Payments
$810.37
2024 Payments
$125.00
Companies
7
Transactions
13
Medicare Patients
1,092
Medicare Billing
$196,870
Payment Breakdown by Category
Food & Beverage$783.88 (96.7%)
Education$26.49 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $783.88 | 11 | 96.7% |
| Education | $26.49 | 2 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BAXTER HEALTHCARE | $420.29 | 4 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $144.83 | 2 | $0 (2021) |
| CALLIDITAS THERAPEUTICS US INC. | $125.00 | 1 | $0 (2024) |
| Novo Nordisk Inc | $56.12 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.08 | 1 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $20.36 | 1 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $19.69 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | CALLIDITAS THERAPEUTICS US INC. ($125.00) |
| 2023 | $20.36 | 1 | Phathom Pharmaceuticals, Inc. ($20.36) |
| 2021 | $232.12 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($144.83) |
| 2020 | $12.60 | 1 | Novo Nordisk Inc ($12.60) |
| 2019 | $122.57 | 1 | BAXTER HEALTHCARE ($122.57) |
| 2018 | $178.99 | 2 | BAXTER HEALTHCARE ($178.99) |
| 2017 | $118.73 | 1 | BAXTER HEALTHCARE ($118.73) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 12/13/2023 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $138.03 | General |
| Category: Cardio-renal | ||||||
| 12/02/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $6.80 | General |
| Category: Cardio-renal | ||||||
| 09/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 06/18/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 03/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Diabetes | ||||||
| 12/10/2019 | BAXTER HEALTHCARE | Renal - PD (Device) | Food and Beverage | In-kind items and services | $122.57 | General |
| Category: Renal | ||||||
| 11/29/2018 | BAXTER HEALTHCARE | Renal - PD (Device) | Food and Beverage | In-kind items and services | $53.83 | General |
| Category: Renal | ||||||
| 04/19/2018 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $125.16 | General |
| Category: Renal | ||||||
| 10/05/2017 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 330 | 733 | $214,352 | $60,907 |
| 2022 | 5 | 290 | 652 | $186,047 | $51,442 |
| 2021 | 4 | 261 | 589 | $172,349 | $48,823 |
| 2020 | 4 | 211 | 407 | $122,079 | $35,698 |
Total Patients
1,092
Total Services
2,381
Medicare Billing
$196,870
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 359 | $75,365 | $23,115 | 30.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 119 | $68,430 | $16,458 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 134 | $40,191 | $12,980 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 44 | $13,123 | $4,005 | 30.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $6,930 | $1,614 | 23.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 14 | 25 | $5,250 | $1,420 | 27.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 34 | $5,062 | $1,316 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 90 | 344 | $72,225 | $19,937 | 27.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 98 | $56,352 | $15,302 | 27.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 63 | 127 | $38,086 | $10,518 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 46 | $13,871 | $4,489 | 32.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 37 | $5,512 | $1,196 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 94 | 320 | $67,160 | $19,125 | 28.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 83 | 89 | $51,179 | $14,070 | 27.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 67 | 145 | $43,477 | $12,216 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 35 | $10,532 | $3,412 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 84 | 233 | $48,965 | $14,142 | 28.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 72 | 76 | $43,702 | $12,965 | 29.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 73 | $21,873 | $6,412 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 25 | $7,539 | $2,179 | 28.9% |
About Dr. Jones John, D.O
Dr. Jones John, D.O is a Nephrology healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972814895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jones John, D.O has received a total of $810.37 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($783.88).
As a Medicare-enrolled provider, John has provided services to 1,092 Medicare beneficiaries, totaling 2,381 services with total Medicare billing of $196,870. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Lauderhill, FL
- Active Since 06/25/2010
- Last Updated 04/24/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1972814895
Products in Payments
- Renal - Non Product Related (Biological) $243.89
- Renal - PD (Device) $176.40
- Kerendia (Drug) $144.83
- TARPEYO (Drug) $125.00
- Ozempic (Drug) $56.12
- TRINTELLIX (Drug) $24.08
- VOQUEZNA (Drug) $20.36
- LUPKYNIS (Drug) $19.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.